IP Library Granted Patent US 9,268,915
Granted Patent B2
US 9,268,915 · App. 13/244,956 · Granted Feb 23, 2016

Systems and methods for diagnosis or treatment

Inventors: Elizabeth Holmes (Palo Alto, CA); Sunny Balwani (Palo Alto, CA)
Assignee: Theranos, Inc.
G06F19/366A61B5/0002A61B5/688A61B5/74A61B8/483A61B10/0045G06F19/3418A61B5/0022A61B5/7232A61B5/7275A61B2010/0003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,268,915
App. No.
13/244,956
Granted
Feb 23, 2016
Kind
B2
Abstract

Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.

Claims (20)

1. A method for diagnosis and/or treatment of a subject with the aid of a point of care system, the method comprising:

(a) authenticating the subject at a point of care location;

(b) obtaining a three-dimensional representation of an external feature of the subject with the aid of a three-dimensional imaging device, wherein the system comprises an image recognition module for analyzing at least a portion of the three-dimensional representation of the external feature of the subject;

(c) obtaining, at the point of care location, a biological sample from the subject;

(d) loading the sample into a cartridge, the cartridge housing a plurality of reagents comprising at least a first reagent and a second reagent, wherein the first reagent is in a first fluidically isolated reagent unit and the second reagent is in a second fluidically isolated reagent unit, and wherein the plurality of reagents in the cartridge are sufficient for performing at least a first assay with the sample;

(e) loading the cartridge comprising the sample and the plurality of reagents into the point of care system, wherein the point of care system comprises i) a camera for obtaining a video image of the subject, ii) an electronic display for displaying a video image of a healthcare provider, iii) an automated pipette, wherein the pipette is configured to access the sample and reagents in the cartridge, and iv) a communications module, for transmitting information to and from the point of care system;

(f) performing the assay in the point of care system, wherein performing the assay comprises accessing and manipulating the sample and the reagents in the cartridge with the automated pipette according to a computer-implemented protocol; and

(g) displaying the video image of the healthcare provider on the display of the point of care system.

2. The method of claim 1 , wherein said authenticating step comprises identifying the subject.

3. The method of claim 2 , wherein identifying the subject includes verifying a fingerprint of the subject.

4. The method of claim 2 , wherein identifying the subject includes verifying a genetic signature of the subject.

5. The method of claim 1 , further comprising obtaining an electrical readout of the subject using a touchscreen display, wherein the electrical readout aids said healthcare provider in providing said diagnosis and/or treatment of said subject.

6. The method of claim 5 , wherein obtaining said electrical readout of the subject using the touchscreen display further comprises making an electrical measurement of the subject through the touchscreen display.

7. The method of claim 1 , wherein the biological sample is obtained from the subject at the location of a healthcare provider.

8. The method of claim 1 , wherein the biological sample is obtained from the subject at the subject's home.

9. The method of claim 1 , wherein step (a) comprises using a biometric scan, the subject's insurance card, the subject's name, the subject's driver's license, an identification card of the subject, an image of the subject taken with the aid of a camera in the point of care system, a genetic signature of the subject, and/or a gesture of the subject to authenticate the subject.

10. The method of claim 1 , further comprising combining the three-dimensional representation of said external feature of the subject with subject-specific information.

11. The method of claim 1 , wherein said biological sample is obtained from said subject with the aid of said point of service system.

12. The method of claim 1 , wherein the three-dimensional representation is obtained and analyzed in real time.

13. The method of claim 1 , wherein said biological sample is a blood sample.

Assignments (5)
CHANGE OF NAME Recorded Apr 3, 2020
From: THERANOS IP COMPANY, LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052313/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 045101/0315 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: THERANOS INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 044838/0909 →
SECURITY INTEREST Recorded Dec 12, 2017
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 044839/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2012
From: HOLMES, ELIZABETH A.; BALWANI, SUNNY
To: THERANOS, INC.
Reel/Frame 028337/0658 →
Continuity (2)
Continuation In Part PCTUS2011053188 · Sep 25, 2011
Related Publication 20130079599A1 · Mar 28, 2013